Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-18 Purchase | 2022-08-22 5:12 pm | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 200,000 | $0.1787 | $35,740 | 400,000 (Indirect Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 3:45 pm | VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER | 300,000 | $0.1697 | $50,910 | 334,629 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-18 3:56 pm | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 600,000 | $0.172 | $103,200 | 780,232 (Indirect Direct) | View |
| 2022-07-12 Sale | 2022-07-14 5:33 pm | VistaGen Therapeutics Inc. | VTGN | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 60,000 | $0.89 | $53,400 | 20,637,286 (Indirect) | View |
| 2021-09-07 Sale | 2021-09-08 6:58 pm | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 30,000 | $3.125 | $93,750 | 72,786 (Direct) | View |
| 2021-08-17 Purchase | 2021-08-18 6:20 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,750 | $2.73 | $10,238 | 94,865 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.748 | 100,111 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.748 | 180,232 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.748 | 19,915 (Direct) | View |
| 2022-04-06 Ownership | 2022-07-08 4:09 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner | 0 | $0 | 20,697,286 (Indirect) | View |
| 2022-05-12 Exercise | 2022-05-16 1:39 pm | N/A 2029-09-05 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 100,000 | $0 | 245,232 (Direct) | View |
| 2022-05-12 Exercise | 2022-05-16 1:39 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 100,000 | $1 | 245,232 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-03 5:10 pm | N/A 2032-05-02 | VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-05-02 Ownership | 2022-05-03 5:07 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Adler Reid G. CHIEF LEGAL OFFICER | 0 | $0 | 282,129 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:17 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:16 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:15 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:14 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:13 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:13 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:12 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:11 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Rotunno Mary L. Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:10 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-11 Exercise | 2022-01-12 5:21 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 18,750 | $0 | 110,196 (Direct) | View |
| 2022-01-11 Exercise | 2022-01-12 5:21 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 18,750 | $1 | 110,196 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:25 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 2,655 | $1.6575 | 14,915 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:20 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 3,575 | $1.6575 | 75,821 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,623 | $1.6575 | 98,859 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:17 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 3,623 | $1.6575 | 75,232 (Direct) | View |
| 2021-08-23 Gift | 2021-09-03 4:19 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 1,851 | $0 | 95,236 (Indirect) | View |
| 2021-07-21 Option Award | 2021-07-22 4:11 pm | N/A 2031-07-21 | VistaGen Therapeutics Inc. | VTGN | FitzPatrick Margaret M Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-07 4:49 pm | N/A 2031-07-06 | VistaGen Therapeutics Inc. | VTGN | Rotunno Mary L. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:11 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 2,260 | $1.9465 | 12,260 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 9,824 | $0.398 | 390,630 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | 2018-08-29 2023-10-27 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 89,742 | $0 | 390,630 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 78,918 | $1 | 390,630 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 3,044 | $1.9465 | 390,630 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 1,000 | $1.5 | 390,630 (Direct) | View |
| 2021-06-30 Disposition | 2021-07-02 4:10 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 36,707 | $0 | 390,630 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $1.9465 | 71,609 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 3,391 | $1.9465 | 91,115 (Direct) | View |
| 2021-05-01 Option Award | 2021-05-04 4:39 pm | N/A 2031-05-01 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0 | 66,609 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $1.5 | 66,609 (Direct) | View |
| 2021-04-23 Option Award | 2021-04-27 4:10 pm | N/A 2031-04-23 | VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director | 75,000 | $0 | 75,000 (Direct) | View |